• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性血清网膜素-1浓度与骨密度

[Serum omentin-1 concentration and bone mineral density in postmenopausal women].

作者信息

Zhang Yunlin, Jiang Yuexia, Tang Siyuan

机构信息

Institute of Endocrinology and Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011,China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Apr;39(4):389-94. doi: 10.3969/j.issn.1672-7347.2014.04.012.

DOI:10.3969/j.issn.1672-7347.2014.04.012
PMID:24820277
Abstract

OBJECTIVE

To determine the relationship between serum omentin-1 concentration and bone mineral desity in postmenopausal women, and the adipose influence of tissue on bone mineral density (BMD).

METHODS

BMD values of 336 participants were measured by dual-energy-x-ray absorptiometry (DEXA) at various skeletal sites: the anteroposterior spine, femeral neck, total hip (T-hip) and total body BMD (TBMD). Body compositions including lean tissue mass (LTM) and body fat mass (FBM) were measured by DEXA. The plasma concentrations of adipocytokines (omentin-1, adiponectin, leptin, resistin, visfatin, and apelin) were measured by ELISA.

RESULTS

The overweight and obese groups had higher T-hip, femerol neck, intertrochanter BMD than the nomal weight group. Plasma omentin-1 was negatively correlated with anteroposterior spine, femeral neck, trochanter, intertrochanter, T-hip and Ward's BMD, after adjustment for age, BMI and fat body mass, and the correlation was not significant. Multiple stepwise regression anlysis revealed that lean body mass, menopause duration and estrogen level were the most important variables affecting the BMD and each explained 12.2%-13.7%, 6.9%-13.1%, 0.9%-1.7% of the variance. Serum adiponectin was independently associated with T-hip, lumbar spine and total BMD.

CONCLUSION

Plasma omentin-1 is not significantly correlated with BMD in postmenopausal women. Lean body mass, menopause duration and estrogen level are the most important variables affecting the BMD. Serum adiponectin is an independent predictor of T-hip, lumbar spine and total BMD.

摘要

目的

确定绝经后女性血清网膜素-1浓度与骨密度之间的关系,以及组织脂肪对骨密度(BMD)的影响。

方法

采用双能X线吸收法(DEXA)测量336名参与者在不同骨骼部位的骨密度值:腰椎前后位、股骨颈、全髋(T-髋)和全身骨密度(TBMD)。通过DEXA测量包括瘦体重(LTM)和体脂量(FBM)在内的身体成分。采用酶联免疫吸附测定法(ELISA)测量脂肪细胞因子(网膜素-1、脂联素、瘦素、抵抗素、内脂素和Apelin)的血浆浓度。

结果

超重和肥胖组的T-髋、股骨颈、大转子间骨密度高于正常体重组。在调整年龄、BMI和脂肪量后,血浆网膜素-1与腰椎前后位、股骨颈、大转子、大转子间、T-髋和Ward三角区骨密度呈负相关,但相关性不显著。多元逐步回归分析显示,瘦体重、绝经持续时间和雌激素水平是影响骨密度的最重要变量,各解释了12.2%-13.7%、6.9%-13.1%、0.9%-1.7%的变异。血清脂联素与T-髋、腰椎和全身骨密度独立相关。

结论

绝经后女性血浆网膜素-1与骨密度无显著相关性。瘦体重、绝经持续时间和雌激素水平是影响骨密度的最重要变量。血清脂联素是T-髋、腰椎和全身骨密度的独立预测因子。

相似文献

1
[Serum omentin-1 concentration and bone mineral density in postmenopausal women].绝经后女性血清网膜素-1浓度与骨密度
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Apr;39(4):389-94. doi: 10.3969/j.issn.1672-7347.2014.04.012.
2
Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women.伊朗绝经后妇女的网膜素-1、内脂素和脂联素水平与骨密度的关系。
Bone. 2012 Nov;51(5):876-81. doi: 10.1016/j.bone.2012.08.117. Epub 2012 Aug 19.
3
Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area.长沙地区健康成年男性血清网膜素-1、体脂量与骨密度之间的关系
J Endocrinol Invest. 2014 Oct;37(10):991-1000. doi: 10.1007/s40618-014-0140-3. Epub 2014 Aug 6.
4
Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women.绝经后中国女性血清脂联素、apelin、瘦素、抵抗素、内脂素水平与骨密度和骨生化标志物的关系。
J Endocrinol Invest. 2010 Nov;33(10):707-11. doi: 10.1007/BF03346674. Epub 2010 Mar 5.
5
Modifications in the spectrum of bone mass predictive factors with menopausal status.骨量预测因素谱随绝经状态的变化。
Endocr Res. 2018 Aug;43(3):176-185. doi: 10.1080/07435800.2018.1448991. Epub 2018 Mar 12.
6
Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.超重及肥胖绝经后女性的骨矿物质密度和骨转换与血清瘦素、α-酮戊二酸及性激素的关系
Clin Endocrinol (Oxf). 2009 Feb;70(2):214-20. doi: 10.1111/j.1365-2265.2008.03313.x. Epub 2008 Jun 10.
7
Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.中国男性血清脂联素、瘦素、抵抗素、内脂素水平与骨密度及骨生化标志物之间的关系
Clin Chim Acta. 2008 Jan;387(1-2):31-5. doi: 10.1016/j.cca.2007.08.012. Epub 2007 Sep 1.
8
Relationship between leptin and adiponectin concentrations in plasma and femoral and spinal bone mineral density in spinal cord-injured individuals.脊髓损伤患者血浆中瘦素和脂联素浓度与股骨及脊柱骨密度之间的关系。
Spine J. 2015 Jan 1;15(1):1-9. doi: 10.1016/j.spinee.2014.06.009. Epub 2014 Jun 16.
9
The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women.胃饥饿素、脂联素和瘦素对健康绝经后女性骨密度的影响。
J Bone Miner Metab. 2008;26(6):618-23. doi: 10.1007/s00774-008-0861-5. Epub 2008 Nov 1.
10
Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.脂联素、内脂素和网膜素在皮下及内脏脂肪组织与血清中的相互作用,及其与临床和外周代谢因子的相关性。
Peptides. 2014 Dec;62:164-75. doi: 10.1016/j.peptides.2014.10.006.

引用本文的文献

1
Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review.新型脂肪因子及其在骨代谢中的作用:一篇叙述性综述。
Biomedicines. 2023 Feb 20;11(2):644. doi: 10.3390/biomedicines11020644.
2
Association of Circulating Omentin-1 with Osteoporosis in a Chinese Type 2 Diabetic Population.循环网膜素-1 与中国 2 型糖尿病患者骨质疏松症的关系。
Mediators Inflamm. 2020 Oct 15;2020:9389720. doi: 10.1155/2020/9389720. eCollection 2020.
3
Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator.
考虑骨保护素作为可能的介质时,网膜素-1、脂联素与骨骼健康之间的关联。
J Endocrinol Invest. 2016 Nov;39(11):1347-1355. doi: 10.1007/s40618-016-0544-3. Epub 2016 Sep 10.